Ranitidine Tablet USP, 150 mg
Drug Labeling and Warnings
Drug Details [pdf]
RANITIDINE- ranitidine tablet
Shasun Pharmaceuticals Limited
----------
Ranitidine Tablet USP, 150 mg
INDICATIONS AND USAGE
- relieves heartburn associated with acid indigestion and sour stomach
- prevents heartburn associated with acid indigestion and sour stomach brought on by certain foods and beverages
OTC - DO NOT USE
- with other acid reducers
- if you have kidney disease, except under the advice and supervision of a doctor
- if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
OTC - ASK DOCTOR
- nausea or vomiting
- stomach pain
- unexplained weight loss
- frequent chest pain
- frequent wheezing, particularly with heartburn
- had heartburn over 3 months. This may be a sign of a more serious condition.
- heartburn with lightheadedness, sweating or dizziness
- chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
OTC - STOP USE
- your heartburn continues or worsens
- you need to take this product for more than 14 days
OTC - PREGNANCY OR BREAST FEEDING
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
DOSAGE AND ADMINISTRATION
adults and children 12 years and over:
○ to relieve symptoms, swallow 1 tablet with a glass of water
○ to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
○ can be used up to twice daily (do not take more than 2 tablets in 24 hours)
○ do not chew tablet
children under 12 years: ask a doctor
STORAGE AND HANDLING
- Blister: do not use if individual unit is open or torn Bottle: do not use of printed foil under bottle cap is open or torn
- store at 20°-25°C (68°-77°F)
- avoid excessive heat or humidity
- this product is sodium and sugar free
INACTIVE INGREDIENT
Colloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide red, magnesium stearte, microcrystalline cellulose, polyethylene glycol, talc, titanium dioxide
| RANITIDINE
ranitidine tablet |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Labeler - Shasun Pharmaceuticals Limited (650064850) |
| Registrant - Strides Shasun Limited (915786829) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
|---|---|---|---|
| Strides Shasun Limited | 915786829 | MANUFACTURE(57910-404) | |